The effect of CDK4/6 inhibitors is cytostatic in cell culture and animal models of solid tumors; in contrast, the effect of CDK4/6 inhibitors is cytotoxic in selected hematological diseases [52]. Here, CDK4 is linked to hematologic disorder.